Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

15.05.2022 | original article

Trends in obesity-related cancer burden in Czechia

verfasst von: Anna Altová

Erschienen in: Wiener klinische Wochenschrift

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Background and objective

Obesity is a major lifestyle risk factor that contributes greatly to the burden of disease, including cancer. Overweight and obesity have shown association with several types of cancer. As Czechia is one of the most overweight countries in Europe, and has high cancer mortality, this study aims to investigate the country’s long-term burden of obesity-related cancer.

Methods

Using the Czech National Cancer Register and the NCD Risk Factor Collaboration (NCD-RisC), standardized incidence and mortality rates were calculated for 12 types of cancer related to obesity for the years 1985–2018. Population attributable fractions (PAF) were calculated. Finally, the standardized attributable rates were calculated from the standardized incidence and mortality rates and the PAFs.

Results

Approximately 11.0% of selected cancer cases in the male population and 12.3% in the female population were attributable to overweight and obesity in 2018. Since the beginning of the millennium, obesity attributable cancer mortality has dropped, while incidence has remained constant. The incidence throughout the whole period was almost twice as high (18.7 cases per 100,000 population in 2018) in women than in men (10.9 cases per 100,000 population in 2018).

Conclusion

Obesity-related cancer mortality in Czechia has declined in the last two decades, but the incidence has remained constant. Given the increasing prevalence of overweight and obesity in western countries, this issue needs to be prioritized in future healthcare and policy making.
Literatur
4.
Zurück zum Zitat Arnold M, Pandeya N, Byrnes G, Renehan AG, Stevens GA, Ezzati M, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 2015;16:36–46. CrossRef Arnold M, Pandeya N, Byrnes G, Renehan AG, Stevens GA, Ezzati M, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 2015;16:36–46. CrossRef
5.
Zurück zum Zitat Berger NA. Obesity and cancer pathogenesis. Ann NY Acad Sci. 2014;1311:57–76. CrossRef Berger NA. Obesity and cancer pathogenesis. Ann NY Acad Sci. 2014;1311:57–76. CrossRef
6.
Zurück zum Zitat Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579–91. CrossRef Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579–91. CrossRef
7.
Zurück zum Zitat Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 2001;161:1581–6. CrossRef Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 2001;161:1581–6. CrossRef
8.
9.
Zurück zum Zitat Arnold M, Touillaud M, Dossus L, Freisling H, Bray F, Margaritis I, et al. Cancers in France in 2015 attributable to high body mass index. Cancer Epidemiol. 2018;52:15–9. CrossRef Arnold M, Touillaud M, Dossus L, Freisling H, Bray F, Margaritis I, et al. Cancers in France in 2015 attributable to high body mass index. Cancer Epidemiol. 2018;52:15–9. CrossRef
10.
Zurück zum Zitat Eurostat. Body mass index (BMI) by sex, age and educational attainment level. 2021. ec.europa.eu/eurostat/web/main/data/database. Accessed 8 Mar 2021. Eurostat. Body mass index (BMI) by sex, age and educational attainment level. 2021. ec.europa.eu/eurostat/web/main/data/database. Accessed 8 Mar 2021.
12.
Zurück zum Zitat Marques A, Peralta M, Naia A, Loureiro N, de Matos MG. Prevalence of adult overweight and obesity in 20 European countries, 2014. Eur J Public Health. 2018;28:295–300. CrossRef Marques A, Peralta M, Naia A, Loureiro N, de Matos MG. Prevalence of adult overweight and obesity in 20 European countries, 2014. Eur J Public Health. 2018;28:295–300. CrossRef
13.
Zurück zum Zitat Bergström A, Pisani P, Tenet V, Wolk A, Adami HO. Overweight as an avoidable cause of cancer in Europe. Int J Cancer. 2001;91:421–30. CrossRef Bergström A, Pisani P, Tenet V, Wolk A, Adami HO. Overweight as an avoidable cause of cancer in Europe. Int J Cancer. 2001;91:421–30. CrossRef
14.
Zurück zum Zitat Rožeková K, Lustigová M. Vplyv nadváhy a obezity na riziko vzniku rakoviny v českej populácii. Demografie. 2019;61:19–27. Rožeková K, Lustigová M. Vplyv nadváhy a obezity na riziko vzniku rakoviny v českej populácii. Demografie. 2019;61:19–27.
21.
Zurück zum Zitat Dušek L, Kubásek M, Kopítková J, Žaloudík J, Vyzula R. Epidemiology of Malignant Tumours in the Czech Republic. Masaryk University, Czech Republic. 2007. svod.cz. Accessed 2 Mar 2021. Dušek L, Kubásek M, Kopítková J, Žaloudík J, Vyzula R. Epidemiology of Malignant Tumours in the Czech Republic. Masaryk University, Czech Republic. 2007. svod.cz. Accessed 2 Mar 2021.
23.
Zurück zum Zitat Bhaskaran K, Douglas I, Forbes H, Dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet. 2014;384:755–65. CrossRef Bhaskaran K, Douglas I, Forbes H, Dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet. 2014;384:755–65. CrossRef
24.
Zurück zum Zitat HMD. Human Mortality Database. University of California, Berkeley (USA), and Max Planck Institute for Demographic Research (Germany). 2021. www.​mortality.​org. Accessed 2 Mar 2021. HMD. Human Mortality Database. University of California, Berkeley (USA), and Max Planck Institute for Demographic Research (Germany). 2021. www.​mortality.​org. Accessed 2 Mar 2021.
28.
Zurück zum Zitat Ahmad OB, Boschi-pinto C, Lopez AD. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series. 2001. Ahmad OB, Boschi-pinto C, Lopez AD. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series. 2001.
29.
Zurück zum Zitat NCD Risk Factor Collaboration (NCD-RisC).. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390:2627–42. CrossRef NCD Risk Factor Collaboration (NCD-RisC).. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390:2627–42. CrossRef
30.
Zurück zum Zitat Ezzati M, Lopez AD, Rodgers A, Murray CJ. Chapter 1, Comparative quantification of health risks: conceptual framework and methodological issues In: Comparative quantification of health risks global and regional burden of disease. Geneva: World Health Organization; 2004. p. 4. ISBN: 9-241-58031-3. Ezzati M, Lopez AD, Rodgers A, Murray CJ. Chapter 1, Comparative quantification of health risks: conceptual framework and methodological issues In: Comparative quantification of health risks global and regional burden of disease. Geneva: World Health Organization; 2004. p. 4. ISBN: 9-241-58031-3.
31.
Zurück zum Zitat Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;108:2205–40. CrossRef Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;108:2205–40. CrossRef
33.
Zurück zum Zitat Aldrich T, Hackley B. The impact of obesity on gynecologic cancer screening: an integrative literature review. J Midwifery Womens Health. 2010;55:344–56. CrossRef Aldrich T, Hackley B. The impact of obesity on gynecologic cancer screening: an integrative literature review. J Midwifery Womens Health. 2010;55:344–56. CrossRef
35.
Zurück zum Zitat Allemani C, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023–75. CrossRef Allemani C, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023–75. CrossRef
36.
Zurück zum Zitat Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10:10–27. CrossRef Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10:10–27. CrossRef
Metadaten
Titel
Trends in obesity-related cancer burden in Czechia
verfasst von
Anna Altová
Publikationsdatum
15.05.2022
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-022-02039-6